XLV ETF Analysis: Health Care Sector Fund | NYSE
Healthcare Equity | NYSE, USA | Market Cap: 49.686m USD | 12M Return: 30.4% | US81369Y2090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.96B
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that seeks to track the performance of a health care-focused index using a replication strategy. The fund invests at least 95% of its total assets in the securities that make up the underlying index, which spans six health care-related industries: pharmaceuticals, health care equipment & supplies, health care providers & services, biotechnology, life sciences tools & services, and health care technology. The fund is classified as non-diversified, meaning it may concentrate its holdings in fewer issuers compared to diversified funds.
Launched in 1998, XLV is one of the nine Select Sector SPDR ETFs that segment the S&P 500 into individual industry sectors, allowing investors to gain targeted exposure to U.S. health care equities. The health care sector is generally regarded as a defensive segment of the market, as demand for medical products and services tends to remain relatively stable regardless of broader economic conditions.
- IRA drug price negotiations pressure pharma profit margins
- GLP-1 obesity drugs drive Eli Lilly sales surge
- Medicare Advantage rate cuts squeeze insurer margins
As of November 11, 2026, the stock is trading at USD 188.88 with a total of 8,916,538 shares traded. Over the past week, the price has changed by +2.64%, over one month by +9.82%, over three months by +12.56% and over the past year by +30.39%.
Current recommended Stop Loss: 184.60 (which is 2.3% or 1.2 ATR below the current price).
Health Care Sector Fund has no consensus analysts rating.